Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program

Go back to Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
(NASDAQ: ASMB) Delayed: 30.15 +0.35 (1.17%)
Previous Close $29.80    52 Week High $14.50 
Open $30.31    52 Week Low $4.33 
Day High $30.48    P/E N/A 
Day Low $29.92    EPS $0.00 
Volume 11,720